Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Archives of Dermatological Research

• Publication date

  2018-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00403-018-1830-zPMID 29605863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Key Regulatory Role of Dermal Fibroblasts in Pigmentation as Demonstrated Using a Reconstructed Skin Model: Impact of Photo-Aging

  2014cited by this paper
• Vitiligo: a complex disease and a complex approach

  2014cited by this paper
• T helper 17 and Tregs: a novel proposed mechanism for NB‐UVB in vitiligo

  2014cited by this paper
• DKK1 is highly expressed in the dermis of vitiligo lesion: is there association between DKK1 and vitiligo?

  2012cited by this paper
• Acral lesions of vitiligo: why are they resistant to photochemotherapy?

  2012cited by this paper
• Immunolocalization of Tenascin-C in Vitiligo

  2012cited by this paper
• Altered levels of Ets‐1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo

  2011cited by this paper
• Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells.

  2010cited by this paper
• Regulation of skin pigmentation and thickness by Dickkopf 1 (DKK1).

  2009influential reference
• Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.

  2009cited by this paper
• The role of tenascin-C in tissue injury and tumorigenesis

  2009cited by this paper
• Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

  2009cited by this paper
• Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non‐segmental vitiligo

  2008cited by this paper
• Histopathologic Features in Vitiligo

  2008cited by this paper
• Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/ β‐catenin signaling in keratinocytes

  2008cited by this paper
• In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation.

  2006cited by this paper
• Interactions between fibroblasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin.

  2006cited by this paper
• Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.

  2004cited by this paper
• A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

  2003cited by this paper
• Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion

  1997cited by this paper
• Extracellular matrix derived from hair and skin fibroblasts stimulates human skin melanocyte tyrosinase activity

  1994cited by this paper
• Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion--functional relatedness to tenascin-C.

  1994cited by this paper
• Structure of the human hexabrachion (tenascin) gene.

  1991cited by this paper
• Tenascin interferes with fibronectin action.

  1988cited by this paper

• Effect of platelet-rich plasma in refractory vitiligo by promoting the differentiation of dermal melanocyte progenitors via IGFBP-2/RhoA/YAP pathway.

  2026cites this paper
• Evaluation of the serum level of Lipocalin 2 in vitiligo

  2025cites this paper
• Vitiligo immunopathogenesis: Insight of immune components and prospects of emerging immunotherapies.

  2025cites this paper
• Fibroblast-Based Therapies for Wrinkles, Wounds, and Vitiligo: A Comprehensive Review.

  2025cites this paper
• Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star.

  2024cites this paper
• The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo

  2024cites this paper
• Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences

  2024cites this paper
• Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics

  2024cites this paper
• Autologous Cultured Tissue Engineering Epidermal Sheet Transplantation to Treat Vitiligo of the Hands

  2024cites this paper
• Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences

  2024cites this paper
• Clinical study of Wnt inhibitory factor-1 expression and its association with disease severity in non-segmental vitiligo

  2024cites this paper
• The possible role of Wnt/β‐catenin signalling in vitiligo treatment

  2023cites this paper
• Melanocyte-keratinocyte cross-talk in vitiligo

  2023cites this paper
• Dermal extracellular matrix molecules in skin development, homeostasis, wound regeneration and diseases.

  2022cites this paper
• Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study

  2022cites this paper
• Association between long noncoding RNA taurine‐upregulated gene 1 and microRNA‐377 in vitiligo

  2021cites this paper
• Is Periungual Vitiligo an Intractable Localization?

  2021cites this paper
• Novel immunological and genetic factors associated with vitiligo: A review

  2021cites this paper
• A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer.

  2020cites this paper
• Premature cell senescence in human skin: dual face in chronic acquired pigmentary disorders.

  2019cites this paper